PL2646005T3 - Sprasowane formulacje uporządkowanych, mezoporowatych krzemionek - Google Patents
Sprasowane formulacje uporządkowanych, mezoporowatych krzemionekInfo
- Publication number
- PL2646005T3 PL2646005T3 PL11822806T PL11822806T PL2646005T3 PL 2646005 T3 PL2646005 T3 PL 2646005T3 PL 11822806 T PL11822806 T PL 11822806T PL 11822806 T PL11822806 T PL 11822806T PL 2646005 T3 PL2646005 T3 PL 2646005T3
- Authority
- PL
- Poland
- Prior art keywords
- ordered mesoporous
- mesoporous silicas
- compressed formulations
- formulations
- compressed
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10192938 | 2010-11-29 | ||
PCT/EP2011/071186 WO2012072580A1 (en) | 2010-11-29 | 2011-11-28 | Compressed formulations of ordered mesoporous silicas |
EP11822806.3A EP2646005B1 (en) | 2010-11-29 | 2011-11-28 | Compressed formulations of ordered mesoporous silicas |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2646005T3 true PL2646005T3 (pl) | 2019-12-31 |
Family
ID=43827090
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL11822806T PL2646005T3 (pl) | 2010-11-29 | 2011-11-28 | Sprasowane formulacje uporządkowanych, mezoporowatych krzemionek |
Country Status (6)
Country | Link |
---|---|
US (1) | US20130243833A1 (pl) |
EP (1) | EP2646005B1 (pl) |
JP (1) | JP2013543881A (pl) |
ES (1) | ES2744926T3 (pl) |
PL (1) | PL2646005T3 (pl) |
WO (1) | WO2012072580A1 (pl) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201212866D0 (en) * | 2012-07-20 | 2012-09-05 | Formac Pharmaceuticals Nv | Dry granulates of mesoporous silica powders |
US20170246111A1 (en) | 2014-09-15 | 2017-08-31 | Pharmasol Gmbh | Active-loaded particulate materials for topical administration |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100624648B1 (ko) * | 1997-12-09 | 2006-09-19 | 에스비에이 머티어리얼스 인코포레이티드 | 메소구조의 무기 산화물을 제조하기 위한 블록 중합체 공정 |
US7563451B2 (en) * | 2003-07-22 | 2009-07-21 | Iowa State University Research Foundation, Inc. | Capped mesoporous silicates |
US20060018966A1 (en) * | 2003-07-22 | 2006-01-26 | Lin Victor S | Antimicrobial mesoporous silica nanoparticles |
CA2721485C (en) * | 2008-04-28 | 2013-12-24 | Formac Pharmaceuticals N.V. | Ordered mesoporous silica material |
AP3250A (en) * | 2009-02-06 | 2015-05-31 | Gilead Sciences Inc | Tablets for combination therapy |
-
2011
- 2011-11-28 ES ES11822806T patent/ES2744926T3/es active Active
- 2011-11-28 WO PCT/EP2011/071186 patent/WO2012072580A1/en active Application Filing
- 2011-11-28 US US13/988,687 patent/US20130243833A1/en not_active Abandoned
- 2011-11-28 EP EP11822806.3A patent/EP2646005B1/en active Active
- 2011-11-28 PL PL11822806T patent/PL2646005T3/pl unknown
- 2011-11-28 JP JP2013540410A patent/JP2013543881A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ES2744926T3 (es) | 2020-02-26 |
WO2012072580A1 (en) | 2012-06-07 |
EP2646005A1 (en) | 2013-10-09 |
EP2646005B1 (en) | 2019-06-26 |
JP2013543881A (ja) | 2013-12-09 |
US20130243833A1 (en) | 2013-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20161771T1 (hr) | Formulacije bendamustina | |
PT2539136T (pt) | Poste de barreira e método de fabrico do mesmo | |
ZA201303567B (en) | Mechanochemical production of zeolites | |
PL2575666T3 (pl) | Sposoby pakowania urządzeń medycznych | |
EP2552210A4 (en) | FORMULAS FROM MAZINDOL | |
IL224192A (en) | Compositions of Vitamin 14 – Epi Analogs d | |
IL223926A0 (en) | Synthesis of cyclopentaquinazolines | |
AP2013006687A0 (en) | Formulations | |
PL2646005T3 (pl) | Sprasowane formulacje uporządkowanych, mezoporowatych krzemionek | |
HK1160777A1 (en) | Novel use of neohesperidoside | |
TWM388919U (en) | Structure of endoscope | |
TWM386036U (en) | Structure of freshness-maintaining box | |
AP2013006689A0 (en) | Formulations | |
TWM402708U (en) | Structure of coffin | |
TWM402707U (en) | Structure of coffin | |
TWM401669U (en) | Improved structure of socket | |
HU1000688D0 (en) | Use of trifluoro-phal | |
GB201003332D0 (en) | Efficient preparation of combination vaccines | |
TWM390349U (en) | Structure of door-in-door | |
TWM386865U (en) | Residue-filtering structure of juice-extractor | |
TWM402171U (en) | Structure of F-handle wrench | |
TWM386872U (en) | Improvement of mop structure | |
GB201009614D0 (en) | Therapeutic use of compounds | |
TWM385984U (en) | Walker structure | |
TWM402652U (en) | Improved structure of table |